Libtayo SJS/TEN Lawsuit Filed Over Fatal Reaction To Skin Cancer Drug
Woman suffered "excruciating pain" before dying from skin reaction that covered 90% of her body in just a couple weeks after receiving Libtayo injections.
Woman suffered "excruciating pain" before dying from skin reaction that covered 90% of her body in just a couple weeks after receiving Libtayo injections.
Lawsuit alleges Taxotere caused epiphora in both eyes, joining a growing number of claims being pursued by former users of the chemotherapy drug left with debilitating watery eyes
Sanofi claims the lawsuits are preempted because Taxotere warning label included information about blocked tear ducts since 2002, despite plaintiffs' arguments the warnings are too vague
Sanofi claims the Taxotere lawsuits over excessive tearing should be dismissed because of a warning added to the label in 2002.
Woman indicates that she was left with a tear duct obstruction from Taxotere, a breast cancer drug, which resulted in debilitating watery eyes
New trial ordered in the first Taxotere bellwether claim that resulted in a defense verdict in 2019, finding that inappropriate expert testimony was introduced by a Sanofi.
MDL Judges said there appear to be at least 100 Taxotere eye injury cases waiting to be filed by plaintiffs who experienced vision problems due excessive tearing and watery eyes caused by Taxotere.
Lawsuits over Taxotere eye injuries have been filed in multiple U.S. District Courts, raising the risk of duplicative discovery into common issues and conflicting pretrial rulings from different judges
Plaintiffs seek to consolidate all Taxotere lawsuits over eye problems before one judge for pretrial proceedings.
Defense verdict in second Taxotere trial out of more than 12,000 lawsuits pending throughout the federal court system over permanent hair loss after the chemotherapy treatment